Clinical trial
Effect of Remimazolam Induction on the Recovery Quality After Day Surgery in Elderly Patients: a Comparison Study With Etomidate
NCT05748665 is registered in ClinicalTrials.gov with Xijing Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Remimazolam Induction on the Recovery Quality After Day Surgery in Elderly Patients: a Comparison Study With Etomidate
- Lead sponsor
- Xijing Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 14, 2023
- Completion date
- January 26, 2024
- Enrollment
- 118 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
ambulatory surgery, elderly patients